Annual report pursuant to Section 13 and 15(d)

Business Combination - Additional Information (Details)

v3.22.1
Business Combination - Additional Information (Details)
$ / shares in Units, $ in Millions
Jul. 14, 2021
USD ($)
$ / shares
shares
Jan. 02, 2022
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Business Acquisition [Line Items]      
Common stock, par value | $ / shares   $ 0.0001 $ 0.0001
Stockholders equity exchange ratio 0.1846    
Common stock, shares issued   152,272,287 100,016,559
Common stock remain reserved for outstanding   27,760,224  
Common stock, shares authorized   1,000,000,000 1,000,000,000
Preferred stock, par value | $ / shares   $ 0.0001 $ 0.0001
Preferred stock, shares authorized   10,000,000 0
Subscription Agreement [Member] | Switchback [Member] | PIPE Financing [Member]      
Business Acquisition [Line Items]      
Issuance of series P-2 Preferred stock Number of shares issued 12,500,000    
Share price | shares | $ / shares $ 14.00    
Issuance of Series P-2 convertible preferred stock | $ $ 175.0    
Legacy Enovix      
Business Acquisition [Line Items]      
Common stock, par value | $ / shares $ 0.0001    
Stockholders equity exchange ratio 0.1846    
Common stock, shares authorized 1,000,000,000    
Preferred stock, par value | $ / shares $ 0.0001    
Preferred stock, shares authorized 10,000,000    
RSVAC [Member]      
Business Acquisition [Line Items]      
Liability assumed | $ $ 73.4    
Common Stock [Member] | Legacy Enovix      
Business Acquisition [Line Items]      
Business acquisition, share price | shares | $ / shares $ 10.00    
Common stock, shares issued 103,995,643    
Common stock remain reserved for outstanding 5,547,327